OTC · CRYO
American CryoStem Corporation
Healthcare · Biotechnology
$0.00
Down-$0.04 (-99.75%)
Updated Aug 13, 2026, 11:10 PM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 4.43K
- P/E ratio
- -0
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 18.75K
- Avg. volume
- 5.17K
Price performance
CRYO price history
1M range · 0 trading sessions · Daily adjusted prices
CRYO does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest CRYO news
The latest Smart Investors Daily articles mentioning CRYO.
Stock researchCompany · Overview
CRYO research
Overview
Company profile and research snapshot.
Company profile
American CryoStem Corporation develops, markets, and licenses adipose tissue derived technologies for use in the fields of Regenerative and Personalized Medicine. The company's products include CELLECT collection, transportation, and storage system, which is a solution for physicians to collect and deliver tissue samples; ATGRAFT adipose tissue storage service, a fat collection, processing, and storage solution that enables physicians to provide their patients with tissue products and cell storage options; and ATCELL adipose derived stem cells. It also offers ACSelerat cell culture media products for growing human stromal cells. In addition, the company, provides contract manufacturing services for Autokine-CM, an anti-aging topical formulation; and autologous skin care product line. American CryoStem Corporation was founded in 1987 and is based in Eatontown, New Jersey.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
